Literature DB >> 20133290

Classification of the thoroughness of mediastinal staging of lung cancer.

Frank Detterbeck1, Jonathan Puchalski, Ami Rubinowitz, David Cheng.   

Abstract

There are many complementary techniques for mediastinal staging of lung cancer. It is increasingly apparent that the accuracy of mediastinal staging depends not only on which test is used but also on technical factors of how the procedure is performed. This article reviews data regarding such technical factors and proposes a classification schema of the thoroughness of execution of mediastinal staging tests. Such a schema is needed for a thoughtful discussion of how mediastinal staging tests should be integrated and for the development of standards of good quality care for patients with non-small cell lung cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20133290     DOI: 10.1378/chest.09-1378

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

Review 1.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Mediastinal staging in daily practice: endosonography, followed by cervical mediastinoscopy. Do we really need both?

Authors:  Ad F Verhagen; Olga C J Schuurbiers; Monika G Looijen-Salamon; Stefan M van der Heide; Henry A van Swieten; Erik H F M van der Heijden
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-09

3.  Optimal route planning for image-guided EBUS bronchoscopy.

Authors:  Xiaonan Zang; Jason D Gibbs; Ronnarit Cheirsilp; Patrick D Byrnes; Jennifer Toth; Rebecca Bascom; William E Higgins
Journal:  Comput Biol Med       Date:  2019-07-26       Impact factor: 4.589

4.  Lung cancer staging: the value of PET depends on the clinical setting.

Authors:  Frank C Detterbeck; Santiago Figueroa Almanzar
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 5.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

6.  Management of screening-detected stage I lung cancer.

Authors:  Raymond U Osarogiagbon
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  External validation of a prediction model for pathologic N2 among patients with a negative mediastinum by positron emission tomography.

Authors:  Farhood Farjah; Leah M Backhus; Thomas K Varghese; James P Manning; Aaron M Cheng; Michael S Mulligan; Douglas E Wood
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 8.  Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis.

Authors:  Erik Folch; Daniel B Costa; Jeffrey Wright; Paul A VanderLaan
Journal:  Transl Lung Cancer Res       Date:  2015-08

9.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study.

Authors:  Macarena R Vial; Oisin J O'Connell; Horiana B Grosu; Mike Hernandez; Laila Noor; Roberto F Casal; John Stewart; Mona Sarkiss; Carlos A Jimenez; David Rice; Reza Mehran; David E Ost; George A Eapen
Journal:  Respirology       Date:  2017-08-30       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.